ketanserin has been researched along with Jejunal Diseases in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Jejunal Diseases: Pathological development in the JEJUNUM region of the SMALL INTESTINE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grondahi, ML | 1 |
| Jensen, GM | 1 |
| Skadhauge, E | 1 |
| Hansen, MB | 1 |
1 other study available for ketanserin and Jejunal Diseases
| Article | Year |
|---|---|
Effect of 5-HT2 and 5-HT3 receptor antagonists on cholera toxin-induced fluid hypersecretion in the pig jejunum.
Topics: Analysis of Variance; Animals; Cholera Toxin; Dose-Response Relationship, Drug; Granisetron; Indoles | 1996 |